Emerging therapeutics for Alzheimer's disease
K Chiang, EH Koo - Annual review of pharmacology and …, 2014 - annualreviews.org
Despite decades of intense research, therapeutics for Alzheimer's disease (AD) are still
limited to symptomatic treatments that possess only short-term efficacy. Recently, several …
limited to symptomatic treatments that possess only short-term efficacy. Recently, several …
Emerging therapeutics for Alzheimer's disease.
K Chiang, EH Koo - Annual Review of Pharmacology and …, 2014 - europepmc.org
Despite decades of intense research, therapeutics for Alzheimer's disease (AD) are still
limited to symptomatic treatments that possess only short-term efficacy. Recently, several …
limited to symptomatic treatments that possess only short-term efficacy. Recently, several …
Emerging therapeutics for Alzheimer's disease
K Chiang, EH Koo - Annual review of pharmacology and …, 2014 - pubmed.ncbi.nlm.nih.gov
Despite decades of intense research, therapeutics for Alzheimer's disease (AD) are still
limited to symptomatic treatments that possess only short-term efficacy. Recently, several …
limited to symptomatic treatments that possess only short-term efficacy. Recently, several …